167 related articles for article (PubMed ID: 19068462)
1. [Examination of somatostatin receptor expression in recurrent childhood medulloblastomas].
Kaszper E; Hanzély Z; Szende B; Dabasi G; Garami M; Schuler D; Hauser P
Magy Onkol; 2008 Dec; 52(4):351-5. PubMed ID: 19068462
[TBL] [Abstract][Full Text] [Related]
2. [Imaging of pediatric brain tumors using somatostatin analogue 111Ih-DTPA-D-Phe1-octreotide].
Dabasi G; Hauser P; Kertész GP; Balázs G; Karádi Z; Constantin T; Bognár L; Klekner A; Schuler D; Garami M
Magy Onkol; 2007; 51(3):229-34. PubMed ID: 17922063
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.
Khanna G; O'Dorisio MS; Menda Y; Glasier C; Deyoung B; Smith BJ; Graham M; Juweid M
Pediatr Blood Cancer; 2008 Mar; 50(3):561-6. PubMed ID: 17387742
[TBL] [Abstract][Full Text] [Related]
5. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
[No Abstract] [Full Text] [Related]
6. A possible role for somatostatin receptor scintigraphy in the diagnosis and follow-up of children with medulloblastoma.
Müller HL; Frühwald MC; Scheubeck M; Rendl J; Warmuth-Metz M; Sörensen N; Kühl J; Reubi JC
J Neurooncol; 1998 May; 38(1):27-40. PubMed ID: 9540055
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors in the brain.
Cavalla P; Schiffer D
Ann Oncol; 2001; 12 Suppl 2():S131-4. PubMed ID: 11762340
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma with extensive nodularity (SHH medulloblastoma).
Fudyma IA; Wadhwani NR
Pol J Pathol; 2017; 68(4):364-366. PubMed ID: 29517209
[TBL] [Abstract][Full Text] [Related]
9. Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma.
Hervey-Jumper SL; Garton HJ; Lau D; Altshuler D; Quint DJ; Robertson PL; Muraszko KM; Maher CO
J Neurosurg Pediatr; 2014 Aug; 14(2):121-8. PubMed ID: 24905841
[TBL] [Abstract][Full Text] [Related]
10. High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy.
Frühwald MC; O'Dorisio MS; Pietsch T; Reubi JC
Pediatr Res; 1999 May; 45(5 Pt 1):697-708. PubMed ID: 10231868
[TBL] [Abstract][Full Text] [Related]
11. 111In-pentetreotide scintigraphy in medulloblastoma: a comparison with magnetic resonance imaging.
Yüksel M; Lutterbey G; Biersack HJ; Elke U; Hasan C; Gao Z; Bode U; Ezziddin S
Acta Oncol; 2007; 46(1):111-7. PubMed ID: 17438713
[TBL] [Abstract][Full Text] [Related]
12. Effect of somatostatin analogue octreotide in medulloblastoma in xenograft and cell culture study.
Hauser P; Hanzély Z; Máthé D; Szabó E; Barna G; Sebestyén A; Jeney A; Schuler D; Fekete G; Garami M
Pediatr Hematol Oncol; 2009; 26(5):363-74. PubMed ID: 19579083
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin-receptor positive brain stem glioma visualized by octreoscan.
Pichler R; Pichler J; Mustafa H; Nussbaumer K; Zaunmüller T; Topakian R
Neuro Endocrinol Lett; 2007 Jun; 28(3):250-1. PubMed ID: 17627256
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of somatostatin receptors in medulloblastoma.
Guyotat J; Champier J; Pierre GS; Jouvet A; Bret P; Brisson C; Belin MF; Signorelli F; Montange MF
J Neurooncol; 2001 Jan; 51(2):93-103. PubMed ID: 11386415
[TBL] [Abstract][Full Text] [Related]
15. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
[TBL] [Abstract][Full Text] [Related]
16. Distribution and functional significance of somatostatin receptors in malignant melanoma.
Lum SS; Fletcher WS; O'Dorisio MS; Nance RW; Pommier RF; Caprara M
World J Surg; 2001 Apr; 25(4):407-12. PubMed ID: 11344389
[TBL] [Abstract][Full Text] [Related]
17. Adult Medulloblastoma Depicted With 99mTc-HYNIC-[D-Phe1, Tyr3-Octreotide] SPECT/CT.
Spyridonidis T; Papathanasiou N; Spiliotopoulou M; Papadimitropoulos C; Apostolopoulos DJ
Clin Nucl Med; 2020 Dec; 45(12):1001-1002. PubMed ID: 33086272
[TBL] [Abstract][Full Text] [Related]
18. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
[TBL] [Abstract][Full Text] [Related]
19. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial.
Longo F; De Filippis L; Zivi A; Vitolo D; Del Signore E; Gori B; Diso D; Anile M; Venuta F; De Giacomo T; Coloni CF
Am J Clin Oncol; 2012 Apr; 35(2):105-9. PubMed ID: 21325939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
